Amla
13 benefits mapped to clinical evidence across supplements.
Dose per serving from products
89 products in our catalogue print how much Amla a serving holds.
Most common: 250 mg to 500 mg, 27% of 89 products.
| Dose per serving | Products |
|---|---|
| 2.5 mg or less | 5 |
| 2.5 mg to 5 mg | 2 |
| 5 mg to 10 mg | 6 |
| 10 mg to 25 mg | 4 |
| 25 mg to 50 mg | 18 |
| 50 mg to 100 mg | 15 |
| 100 mg to 250 mg | 9 |
| 250 mg to 500 mg | 24 |
| 500 mg to 1 g | 5 |
| over 1 g | 1 |
Dose per serving from research
14 study groups in 8 studies say how much Amla participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 500 mg to 1 g, 50% of 14 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg to 10 mg | 1 |
| 10 mg to 25 mg | 1 |
| 25 mg to 50 mg | 1 |
| 50 mg to 100 mg | 0 |
| 100 mg to 250 mg | 0 |
| 250 mg to 500 mg | 3 |
| 500 mg to 1 g | 7 |
| 1 g to 2.5 g | 0 |
| over 2.5 g | 1 |
Benefit Evidence
Research sources
Oral health (11)
- Efficacy of Improvised Topical Zinc (1%) Ora-Base on Oral Mucositis during Cancer Chemo-Radiation-A Randomized Study
PubMed ID: 32350185
Topical preparation containing Amla reduced chemo/radiation mucositis severity vs control — supports oral mucosal protection/healing.
- The effects of a novel herbal toothpaste on salivary lactate dehydrogenase as a measure of cellular integrity
PubMed ID: 33064207
Multi‑herbal toothpaste with Amla produced modest but significant reductions in salivary LDH, plaque and gingivitis vs control in a double‑blind study.
- A randomized clinical study to examine the oral hygiene efficacy of a novel herbal toothpaste with zinc over a 6-month period
PubMed ID: 33866666
Large 6‑month randomized trial: routine use of herbal/zinc toothpaste containing Amla significantly improved plaque control, gingival inflammation and bleeding vs fluoride control.
- Assessment of antibacterial efficacy of triphala against mutans streptococci: a randomised control trial
PubMed ID: 22238738
Randomized double‑blind trial: 6% triphala mouthwash (contains Amla) produced large reductions in mutans streptococci comparable to chlorhexidine.
- Antibacterial efficacy of triphala against oral streptococci: an in vivo study
PubMed ID: 23422630
Triphala rinse markedly reduced salivary streptococci at 48 h and 7 days similar to chlorhexidine — robust short‑term antimicrobial oral effect.
- Antiplaque and antigingivitis efficacy of triphala and chlorhexidine mouthrinse among schoolchildren - a cross-over, double-blind, randomised controlled trial
PubMed ID: 25197734
Double‑blind crossover RCT in adolescents: 10% triphala rinse reduced plaque and gingivitis comparable to 0.2% chlorhexidine — strong clinical antiplaque/antigingivitis evidence.
- Efficacy of triphala mouth rinse (aqueous extracts) on dental plaque and gingivitis in children
PubMed ID: 24850703
Schoolchildren trial: aqueous triphala mouthrinse significantly reduced plaque and gingivitis, comparable to chlorhexidine — supports pediatric oral benefit.
- Effect of Subgingivally Delivered 10% Emblica officinalis Gel as an Adjunct to Scaling and Root Planing in the Treatment of Chronic Periodontitis - A Randomized Placebo-controlled Clinical Trial
PubMed ID: 26914986
Randomized controlled trial: adjunctive sustained‑release 10% Emblica gel plus SRP improved pocket depth, attachment and bleeding vs SRP alone — direct periodontal benefit.
- "Nature cures:" An alternative herbal formulation as a denture cleanser
PubMed ID: 28300045
Triphala denture cleanser (includes Amla) significantly reduced Candida colony counts over 30 days, comparable or superior to chlorhexidine.
- Antibacterial and anti-inflammatory effects of a novel herb-mediated nanocomposite mouthwash in plaque-induced gingivitis: A randomized controlled trial
PubMed ID: 37796050
15‑day RCT of an amla‑seed graphene–silver mouthwash reduced plaque and gingival inflammation vs baseline, demonstrating tangible oral‑health effects (small, short study; less effective than chlorhexidine).
- Phyllanthus emblica fruit extract alleviates halitosis and reduces the inflammatory response to oral bacteria
PubMed ID: 38922243
Converging in vitro, ex vivo and clinical data show strong reduction in VSC (halitosis), antibacterial activity and lowered oral inflammation across short- and longer-term use.
Inflammation (7)
- Effect of Subgingivally Delivered 10% Emblica officinalis Gel as an Adjunct to Scaling and Root Planing in the Treatment of Chronic Periodontitis - A Randomized Placebo-controlled Clinical Trial
PubMed ID: 26914986
10% Emblica gel adjunct reduced periodontal bleeding and inflammation versus SRP alone (RCT).
- A randomized clinical study to examine the oral hygiene efficacy of a novel herbal toothpaste with zinc over a 6-month period
PubMed ID: 33866666
Six‑month herbal/zinc toothpaste (includes Amla) produced large reductions in gingival inflammation and bleeding — consistent with anti‑inflammatory action in the oral cavity.
- Efficacy of Improvised Topical Zinc (1%) Ora-Base on Oral Mucositis during Cancer Chemo-Radiation-A Randomized Study
PubMed ID: 32350185
Topical improvised paste containing Amla reduced severity/duration of chemo/radiation mucositis versus control — local anti‑inflammatory/repair effect.
- The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial
PubMed ID: 35093510
Add‑on Amla in COVID hastened CRP normalization and clinical recovery — indicates systemic anti‑inflammatory effect in that setting.
- Phyllanthus emblica fruit extract alleviates halitosis and reduces the inflammatory response to oral bacteria
PubMed ID: 38922243
Clinical and in vitro data showed decreased IL-6/IL-8 and reduced oral inflammatory markers/VSCs—clear anti‑inflammatory effects in the oral setting.
- Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study
PubMed ID: 31060549
Marked reductions in oxidative‑stress marker MDA (−21% to −31%) and improved endothelial indices — strong anti‑inflammatory/antioxidant signal.
- Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial
PubMed ID: 29526236
Oral Amla tablets reduced heartburn/regurgitation in NERD — symptomatic improvement plausibly via local anti‑inflammatory/acid‑modulating effects.
Skin appearance (4)
- Oral intake of lingonberry and amla fruit extract improves skin conditions in healthy female subjects: A randomized, double-blind, placebo-controlled clinical trial
PubMed ID: 31342566
12‑week trial with lingonberry+Amla extracts improved skin elasticity, thickness and hydration — tangible anti‑aging skin benefits (combination product).
- Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study
PubMed ID: 31060549
Reduction in oxidative stress markers and improved endothelial function in metabolic syndrome may contribute to slowing age‑related vascular/oxidative changes.
- Optimized multiherbal combination and in vivo anti-skin aging potential: a randomized double blind placebo controlled study
PubMed ID: 37024608
The topical, multi‑herbal cream improved skin appearance measures (hydration/elasticity/wrinkle reduction), suggesting clearer/healthier complexion though not solely attributable to amla.
- Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening
PubMed ID: 21049734
Topical product containing Emblica extract lightened facial hyperpigmentation comparably to hydroquinone in a double‑blind trial — direct evidence for complexion improvement.
Heart health (3)
- Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study
PubMed ID: 31060549
Improved endothelial function (reflection index), reduced MDA and LDL in metabolic‑syndrome patients — supports vascular/cardiac health.
- A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
PubMed ID: 30670010
Well‑powered RCT with full‑spectrum Amla extract showing large, clinically meaningful reductions in TG, TC and LDL — strong cardiometabolic support.
- Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial
PubMed ID: 40573153
Flow‑mediated dilation (endothelial function) increased in PE arms at 12 weeks—supports cardiovascular/endothelial benefit (modest effect).
Metabolism (3)
- A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
PubMed ID: 30670010
Large double‑blind RCT showing substantial improvements in TG/TC/LDL with full‑spectrum Amla extract — strong direct metabolic benefit.
- Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study
PubMed ID: 31060549
Dose‑dependent improvements in endothelial function, reduced oxidative stress and LDL in metabolic‑syndrome patients — supports metabolic health.
- Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial
PubMed ID: 40573153
12-week RCT showed modest improvements in glucose and body-composition/endothelial markers consistent with metabolic support (effects modest/inconsistent).
Skin health (3)
- Optimized multiherbal combination and in vivo anti-skin aging potential: a randomized double blind placebo controlled study
PubMed ID: 37024608
60‑day randomized, double‑blind trial of an amla‑containing herbal cream showed meaningful improvements in hydration, elasticity and wrinkles, but attribution to amla alone is uncertain (multi‑herbal product).
- Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening
PubMed ID: 21049734
Topical formulation containing Emblica extract lightened hyperpigmentation comparably to hydroquinone in a 12‑week double‑blind trial — supports skin‑improving activity.
- Oral intake of lingonberry and amla fruit extract improves skin conditions in healthy female subjects: A randomized, double-blind, placebo-controlled clinical trial
PubMed ID: 31342566
Randomized double‑blind trial of lingonberry+Amla drinks improved skin elasticity, thickness and hydration after 12 weeks — clear dermatologic benefit (combination product).
Immune support (2)
- The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial
PubMed ID: 35093510
Faster clinical recovery and higher CRP negativity in hospitalized COVID patients with add‑on Amla suggests an immunomodulatory / host‑response benefit in this small trial.
- Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: a phase II randomized controlled study
PubMed ID: 24289574
Topical Basant cream (contains Amla) increased HPV clearance vs placebo — improved pathogen clearance in a large RCT though multiple actives confound attribution.
Antioxidant (2)
- Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study
PubMed ID: 31060549
Dose‑dependent reductions in MDA (−21% and −31%) and improved endothelial function indicate robust antioxidant effects in metabolic syndrome subjects.
- A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
PubMed ID: 30670010
Large RCT showed marked lipid improvements; while primarily metabolic, the trial also supports antioxidant/atheroprotective mechanisms plausibly linked to Amla.
Blood sugar (1)
- Effects of 12 Weeks of Chromium, Phyllanthus emblica Fruit Extract, and Shilajit Supplementation on Markers of Cardiometabolic Health, Fitness, and Weight Loss in Men and Women with Risk Factors to Metabolic Syndrome Initiating an Exercise and Diet Intervention: A Randomized Double-Blind, Placebo-Controlled Trial
PubMed ID: 40573153
Fasting glucose/HbA1c decreased in the PE-1000 arm at 12 weeks in a randomized trial, indicating a moderate glucose‑balancing signal (modest/inconsistent overall).
Digestive support (1)
- Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial
PubMed ID: 29526236
Double‑blind RCT: oral Amla tablets (1 g twice daily) significantly reduced heartburn and regurgitation in NERD vs placebo — direct digestive symptom benefit.
Hair growth (1)
- The effect of an oral product containing Amla fruit (Phyllanthus emblica L.) on female androgenetic alopecia: A randomized controlled trial
PubMed ID: 37487962
Triple‑blind RCT: oral Amla syrup increased anagen:telogen ratio and improved clinician/patient satisfaction for female pattern hair loss — direct, objective hair benefit.
Respiratory comfort (1)
- The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial
PubMed ID: 35093510
Add‑on Amla sachets/tea in hospitalized COVID‑19 patients improved SpO2 substantially (≈+4.6 pp) and shortened hospital stay — direct respiratory/oxygenation benefit in this small RCT.
Weight management (1)
- Effect of Amla Extract on Body Mass Index, Waist Circumference, Total Body Fat, Visceral Fat, Skeletal Muscle Mass, Body Age, and Related Parameters: A Randomized, Open-Label Clinical Study in Obese Participants
PubMed ID: 40262554
Open-label 90-day trial found significant reductions in visceral fat and waist and increased muscle mass versus baseline (strongest direct weight/body‑composition evidence).
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Amla
Search all415 products whose verified label declares Amla — not every bottle that mentions it in a title.